Apeloa Pharmaceutical Hits Day Low of CNY 19.47 Amid Price Pressure

Apeloa Pharmaceutical Co., Ltd. experienced a significant decline in its stock performance on July 17, 2026, with a drop of 6.43%. The stock reached an intraday low of CNY 19.47, reflecting a challenging day for the company in the pharmaceuticals and biotechnology sector. Despite this downturn, Apeloa has shown resilience in its longer-term performance metrics. Over the past year, the company has achieved a 32.68% increase, significantly outperforming the China Shanghai Composite, which rose only 7.03% during the same period. Additionally, Apeloa's year-to-date performance stands at 20.77%, contrasting with the composite's decline of 5.16%. However, the company has faced difficulties in recent quarters, reporting negative results for six consecutive periods. Key financial indicators reveal a net sales figure of CNY 4,467.13 million, which has decreased by 18.04%. The return on capital employed (ROCE) is at a low of 13.15%, and the interest coverage ratio is notably high at 4,010.49. These metrics highlight the complexities surrounding Apeloa's current market position and financial health.